Form 4 for TNON Tenon Medical, Inc.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001575872-23-000846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-22 | TNON | FOSTER STEVEN M | CEO, Pres, Dir | M - OptEx | $1.62 | +72.5K | 72.5K | New | +$117.4K | |
| 2023-05-24 | 2023-05-23 | TNON | FOSTER STEVEN M | CEO, Pres, Dir | S - Sale+OE | $1.26 | -27.8K | 44.7K | -38% | -$35.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-22 | M | A | 72,477 | $1.62 | 72,477 | D | — | — | (F1) These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. |
| 2 | Common | Common Stock | 2023-05-23 | S | D | 27,791 | $1.26 | 44,686 | D | — | — |